ImageneBio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for ImageneBio, Inc. (IMA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021
Period EndingDec 2024Dec 2023Dec 2022Dec 2021
Current Assets
Cash and Cash Equivalents12.1215.32156.95232.22
Short-Term Investments84.9910.150.000.00
Cash & Short-Term Investments12.1225.47156.95232.22
Accounts Receivable0.080.220.000.00
Inventory0.000.000.000.00
Other Current Assets0.210.200.960.63
Total Current Assets12.4725.90160.01236.52
Non-Current Assets
Property, Plant & Equipment (Net)0.564.288.468.98
Other Non-Current Assets2.901.070.000.00
Total Non-Current Assets3.455.3512.2511.36
Total Assets15.9231.25172.26247.88
Current Liabilities
Accounts Payable5.295.882.092.38
Short-Term Debt7.500.000.000.00
Accrued Liabilities2.531.990.000.00
Deferred Revenue0.650.070.000.00
Other Current Liabilities6.108.588.345.85
Total Current Liabilities17.219.4921.5027.19
Non-Current Liabilities
Long-Term Debt0.240.573.795.14
Other Non-Current Liabilities1.060.000.000.00
Total Non-Current Liabilities159.28147.863.7912.81
Total Liabilities176.49157.3525.2940.00
Stockholders' Equity
Common Stock0.020.010.000.00
Retained Earnings-179.90-143.33-214.98-145.45
Accumulated Other Comprehensive Income-1.79-1.750.000.00
Additional Paid-in Capital2.14452.14361.92353.30
Shares Outstanding11.1811.180.000.00
Total Stockholders' Equity-160.57-126.11146.97207.88
Total Liabilities & Equity15.9231.25172.26247.88